loading page

Biocompatibility of Biomaterials
  • +2
  • Hemant Raut,
  • Rupambika Das,
  • Ziqian Liu,
  • Liu Xiaoling,
  • Seeram Ramakrishna
Hemant Raut
Singapore University of Technology and Design
Author Profile
Rupambika Das
Singapore University of Technology and Design
Author Profile
Ziqian Liu
University of Nottingham - Ningbo China
Author Profile
Liu Xiaoling
University of Nottingham - Ningbo China
Author Profile
Seeram Ramakrishna
National University of Singapore
Author Profile

Peer review status:ACCEPTED

07 Apr 2020Submitted to Biotechnology Journal
09 Apr 2020Submission Checks Completed
09 Apr 2020Assigned to Editor
09 Apr 2020Reviewer(s) Assigned
27 Apr 2020Editorial Decision: Revise Major
02 Jun 20201st Revision Received
03 Jun 2020Assigned to Editor
03 Jun 2020Submission Checks Completed
03 Jun 2020Reviewer(s) Assigned
16 Jun 2020Editorial Decision: Revise Minor
19 Jun 20202nd Revision Received
22 Jun 2020Submission Checks Completed
22 Jun 2020Assigned to Editor
22 Jun 2020Reviewer(s) Assigned
28 Jun 2020Editorial Decision: Accept

Abstract

There is a vast number of biomaterials ranging from drug-eluting stents, coated implants, drug delivery devices and artificial organs, among others, that have been developed in recent years. However, translation of many of these biomaterials to clinic is often plagued by biocompatibility challenges. This review focuses on strategies implemented in some of the recently developed biomaterials -- particularly for soft and hard tissue regeneration, organ manufacturing and disease remediation -- to overcome potential foreign body response to the incorporation of the biomaterials in the host.